Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Primer group, kit and library construction method for detecting five bloodstream infection pathogens,

A technology of pathogens and primer sets, applied in the direction of microorganism-based methods, biochemical equipment and methods, microorganisms, etc., can solve the problems of increased signal detection load, low scalability, poor scalability, etc., to reduce non-specific amplification , avoid false positives, and reduce testing costs

Pending Publication Date: 2020-04-07
深圳华大因源医药科技有限公司 +1
View PDF7 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the identification of this method depends on the change of temperature, so the temperature sensitivity of the equipment is very high; in addition, only one sample can be detected at a time, and the throughput is low; the species judgment depends on the temperature change, so the scalability of the identification of species Low
2) Prove-it in Finland TM Sepsis (Mobidiag, Finland) bloodstream infection detection product can identify 19 kinds of Gram-negative bacteria, 15 kinds of Gram-positive bacteria, 8 kinds of fungi and drug-resistant genes within 3.5 hours through multiplex PCR and hybridization. Multiplex PCR itself has technical limitations and low scalability. In addition, hybridization-based methods are prone to non-specific hybridization and affect the accuracy of detection results.
However, due to the limitations of 16S identification, some targets could not be identified to the species level
4) Luminex Bloodstream Infection Pathogen Multiple Detection Kit ( Liquid phase chip method) is a method based on multiplex PCR and liquid phase capture to realize the detection of specific pathogens, but due to the limitation of fluorescence detection resolution of this method, the detection sensitivity is not high
[0005] The existing bloodstream infection detection technology or products have the following defects: 1) The scalability of detecting pathogens is low
The multiplex PCR detection technology represented by Filmarray, after multiplex PCR amplification, can be distinguished by melting curve or detected by fluorescent signal. Due to the limitations of the technology itself, the expansion of the multiplex PCR system may affect the system on the one hand. On the other hand, it will increase the load of subsequent signal detection, so this type of technology has poor scalability and high technical limitations
2) Pathogen resolution is low
MagicPlex by Seegene TM Take sepsis real-time detection as an example. Since 16S primers are used for detection, some primers can only identify species at the genus level, but cannot be accurate to the species level, and cannot accurately distinguish specific species.
3) The false positive rate of test results is high
Most of the molecular multiple detection products currently on the market detect target molecules through indirect detection of sequence signals, during which false positives may occur due to non-specific amplification or other chimerism
4) Low detection throughput
Taking Filmarray as an example, a single test can only detect one sample, which is far from meeting the clinical throughput requirements
5) Low detection sensitivity
Filmarray detection sample type is blood culture, which is suitable for detection of high-concentration target samples; Luminex bloodstream infection pathogen multiplex detection kit can directly detect whole blood samples, but its detection sensitivity is low, generally only up to 10^ 4 to 10^5 copies / ml

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Primer group, kit and library construction method for detecting five bloodstream infection pathogens,
  • Primer group, kit and library construction method for detecting five bloodstream infection pathogens,
  • Primer group, kit and library construction method for detecting five bloodstream infection pathogens,

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0073] Select clinical blood culture positive samples and negative whole blood samples and R10 and R11 negative and positive control substances (as shown in Table 2) for testing, a total of 10 samples.

[0074] 1) Sample pretreatment and nucleic acid extraction:

[0075] Take 450 μL whole blood sample and add it to a 2.0 mL centrifuge tube pre-installed with 250 μL 0.5mm glass beads, seal the tube opening with a parafilm, shake at room temperature for 20 minutes, remove the sealing film after the shaking is completed, and put the centrifuge tube into a centrifuge for centrifugation at 8000rpm 30s, use a pipette to carefully draw 200 μL of the whole blood sample after breaking the wall for nucleic acid extraction. The nucleic acid extraction process was performed according to the instructions of the MagPureBlood DNA KF Kit, and the final melting volume of the nucleic acid was 40 μL.

[0076] 2) Extract nucleic acid purification

[0077] Purify the extracted nucleic acid with 1 ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a primer group, a kit and a library construction method for detecting five bloodstream infection pathogens. The primer group comprises primer pairs used for detecting staphylococcus aureus, escherichia coli, acinetobacter baumannii, klebsiella pneumonia and enterococcus faecium. The primer group disclosed by the invention is high in specificity, a situation of non-specificamplification is effectively reduced, and the culture level of bacteria can be directly authenticated through specific primer amplification. When the primer group disclosed by the invention is adoptedto detect the bloodstream infection pathogens, a blood culture operation is not required, pathogens in a blood sample can be directly detected, the shortest time for obtaining a detection result is 48 h, and a detection period is greatly shortened.

Description

technical field [0001] The invention relates to the technical field of pathogenic microorganism detection, in particular to a primer set, a kit and a method for building a library for detecting five bloodstream infection pathogens. Background technique [0002] Bloodstream infection is a serious systemic infectious disease. The current clinical diagnosis method is still based on blood culture, which takes a long time and has a low positive culture rate, which is not conducive to timely diagnosis and medication judgment. Clinically, drugs are often prescribed based on doctors’ empirical diagnosis. On the one hand, it increases the economic burden of patients, and on the other hand, it also increases the risk of drug resistance caused by antibiotic abuse. Therefore, accurate and rapid detection of pathogens is the current trend of clinical diagnosis. [0003] Using the method of multiple target enrichment can realize the simultaneous detection of different targets in the sampl...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12Q1/689C12Q1/14C12Q1/10C12Q1/04C12N15/11C40B50/06C12Q1/686C12R1/445C12R1/19C12R1/22C12R1/01
CPCC12Q1/689C40B50/06C12Q1/686C12Q2600/16C12Q2537/143C12Q2525/191C12Q2521/501Y02A50/30
Inventor 申奥宫艳萍李英镇袁剑颖吴红龙
Owner 深圳华大因源医药科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products